Key result
Expression of Concern flags homocysteine study over incorrect antibody use and duplicated western blot data.
Why the study?
The Editorial Office was made aware of potential issues surrounding the scientific integrity of the previously published article, including the reported use of an antibody targeting PERK rather than p-ERK and western blot data bearing a close resemblance to data in other papers.
This is an Expression of Concern regarding potential scientific integrity issues, including the use of an incorrect antibody (targeting PERK instead of p-ERK) and duplicated western blot data in a previously published basic science study.
Answers are grounded in this paper and cite their sources.
Prompts caution interpreting homocysteine-ERK myocardial I/R data; challenges pathway validity and leaves mechanistic role open pending correction.
Subsequently to the publication of the above article, a concerned reader has drawn the Editor's attention to the fact that an inappropriately selected antibody was reported to have been used to probe for phosphorylated ERK (or p‑ERK) in the western blot experiments shown in Figs. 1 and 3: The catalogue number for the antibody was reported in the Materials and methods section to have been ab192591 (purchased from Abcam), whereas this antibody does not target p‑ERK, but protein kinase RNA‑like ER kinase (also known as EIF2AK3), having the acronym ‘PERK’. In addition, an independent analysis of the data in this paper performed by the Editorial Office revealed that certain of the western blot data shown in Fig. 3 on p. 942 bear a close resemblance to western blot data that have subsequently appeared in other papers in different journals that were written by different authors at different research institutes. The authors have been contacted by the Editorial Office to offer an explanation for the apparently incorrect selection of an antibody in this paper, and we are awaiting their response. Owing to the fact that the Editorial Office has been made aware of a potential issue surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of these potential problems while the Editorial Office continues to investigate this matter further. [Experimental and Therapeutic Medicine 20: 938‑944, 2020; DOI: 10.3892/etm.2020.8735]
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied Myocardial ischemia/reperfusion injury. Homocysteine was evaluated. An Expression of Concern was issued for this homocysteine study due to use of an incorrect antibody in Figs. 1 and 3 and duplicated western blot data in Fig. 3.
Synapse has enriched 10 related papers. Consider them for comparative context: